ImmuCell Corporation

NASDAQ: ICCC · Real-Time Price · USD
5.36
0.09 (1.71%)
At close: May 19, 2025, 2:26 PM

ImmuCell Statistics

Share Statistics

ImmuCell has 9.04M shares outstanding. The number of shares has increased by 14.08% in one year.

Shares Outstanding 9.04M
Shares Change (YoY) 14.08%
Shares Change (QoQ) 0%
Owned by Institutions (%) 14.76%
Shares Floating n/a
Failed to Deliver (FTD) Shares 2,000
FTD / Avg. Volume 9.3%

Short Selling Information

The latest short interest is 6.39K, so 0.07% of the outstanding shares have been sold short.

Short Interest 6.39K
Short % of Shares Out 0.07%
Short % of Float 0.09%
Short Ratio (days to cover) 1

Valuation Ratios

The PE ratio is -19.5 and the forward PE ratio is -48.36. ImmuCell's PEG ratio is 0.3.

PE Ratio -19.5
Forward PE -48.36
PS Ratio 1.59
Forward PS 2.5
PB Ratio 1.53
P/FCF Ratio -390.09
PEG Ratio 0.3
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for ImmuCell.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.41, with a Debt / Equity ratio of 0.55.

Current Ratio 3.41
Quick Ratio 1.8
Debt / Equity 0.55
Debt / EBITDA 14.46
Debt / FCF -140.04
Interest Coverage -2.88

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $383,958.97
Profits Per Employee $-31,255.49
Employee Count 69
Asset Turnover 0.59
Inventory Turnover 2.61

Taxes

Income Tax 10.06K
Effective Tax Rate -0.47%

Stock Price Statistics

The stock price has increased by 8.94% in the last 52 weeks. The beta is 0.24, so ImmuCell's price volatility has been higher than the market average.

Beta 0.24
52-Week Price Change 8.94%
50-Day Moving Average 5.15
200-Day Moving Average 4.49
Relative Strength Index (RSI) 51.6
Average Volume (20 Days) 21,513

Income Statement

In the last 12 months, ImmuCell had revenue of 26.49M and earned -2.16M in profits. Earnings per share was -0.26.

Revenue 26.49M
Gross Profit 7.94M
Operating Income -1.64M
Net Income -2.16M
EBITDA 1.04M
EBIT -1.62M
Earnings Per Share (EPS) -0.26
Full Income Statement

Balance Sheet

The company has 3.76M in cash and 15.1M in debt, giving a net cash position of -11.34M.

Cash & Cash Equivalents 3.76M
Total Debt 15.1M
Net Cash -11.34M
Retained Earnings -14.16M
Total Assets 45.62B
Working Capital 12.05B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 357.9K and capital expenditures -465.73K, giving a free cash flow of -107.82K.

Operating Cash Flow 357.9K
Capital Expenditures -465.73K
Free Cash Flow -107.82K
FCF Per Share -0.01
Full Cash Flow Statement

Margins

Gross margin is 29.97%, with operating and profit margins of -6.19% and -8.14%.

Gross Margin 29.97%
Operating Margin -6.19%
Pretax Margin -8.1%
Profit Margin -8.14%
EBITDA Margin 3.94%
EBIT Margin -6.19%
FCF Margin -0.41%

Dividends & Yields

ICCC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for ICCC.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

The last stock split was on Jul 25, 1990. It was a backward split with a ratio of 1:100.

Last Split Date Jul 25, 1990
Split Type backward
Split Ratio 1:100

Scores

Altman Z-Score 0.15
Piotroski F-Score 7